金斯瑞生物科技股份有限公司（01548）于2026年3月3日发布截至2026年2月28日的股份变动月报表。公告显示，截至本月底，公司注册股本维持为5,000,000美元（对应5,000,000,000股，每股面值0.001美元），与上月底相同。
报告期内，公司已发行股份总数仍为2,186,518,520股，与上月底相比没有新增发行、购回、注销或库藏股变化。公司现行股份期权计划未导致任何新股发行或库藏股转让，期末累计可行使期权数为25,641,294份。
公司强调已符合适用的公众持股量要求，并重申在运营及资本结构上继续遵循香港联合交易所有限公司上市规则。公告由董事孟建革签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.